Bill Status of SB 1258   104th General Assembly

Short Description:  PRIOR AUTH-PRESCRIPTION DRUGS

Senate Sponsors
Sen. Graciela Guzmán and Rachel Ventura

Last Action  View All Actions

DateChamber Action
  5/9/2025SenateRule 3-9(a) / Re-referred to Assignments

Statutes Amended In Order of Appearance
215 ILCS 200/52 new

Synopsis As Introduced
Amends the Prior Authorization Reform Act. Provides that a health insurance issuer may not require prior authorization for: a prescription drug prescribed to a patient by a health care professional for 6 or more consecutive months, regardless of whether the prescription drug is a non-preferred medication pursuant to the patient's health insurance coverage; the following prescription drugs or the therapeutic equivalent approved by the United States Food and Drug Administration: insulin; human immunodeficiency virus prevention medication; human immunodeficiency virus treatment medication; viral hepatitis medication; estrogen; and progesterone; or human immunodeficiency virus pre-exposure prophylaxis and post-exposure prophylaxis drugs approved by the United States Food and Drug Administration; Truvada; Harvoni; Descovy; and Apretude.

Actions 
DateChamber Action
  1/28/2025SenateFiled with Secretary by Sen. Graciela Guzmán
  1/28/2025SenateFirst Reading
  1/28/2025SenateReferred to Assignments
  3/4/2025SenateAdded as Co-Sponsor Sen. Rachel Ventura
  3/12/2025SenateAssigned to Insurance
  3/21/2025SenateRule 2-10 Committee Deadline Established As April 4, 2025
  4/4/2025SenateRule 2-10 Committee Deadline Established As April 11, 2025
  4/11/2025SenateRule 2-10 Committee/3rd Reading Deadline Established As May 9, 2025
  5/9/2025SenateRule 3-9(a) / Re-referred to Assignments

Back To Top